We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Software Enables Unattended Scanning and Image Capture for Cytogenetic Analysis

By LabMedica International staff writers
Posted on 25 Nov 2009
An automatic slide loader system is installed and running in clinical and research laboratories in North America, Middle East, Asia Pacific, Europe, and also has been purchased by a commercial clinical laboratory in Japan.

The system is capable of processing up to 120 slides per batch, while feeding images directly to review stations for on-screen analysis by cytogeneticists. More...
Laboratories have reported shortened turnaround times and reduced backlogs of patient samples. The installations are used for a variety of applications, predominantly karyotyping, but also other brightfield and fluorescence-based applications.

Genetix' (New Milton, UK) GSL-120 automatic slide loader system is used under the control of the company's CytoVision software platform. In diagnostics, Genetix holds a leading position in genetic testing with thousands of the company's platforms used in laboratories worldwide.

Satisfaction with the system was expressed by Sydney Genetics, a private cytogenetics laboratory, and a subsidiary of Sydney in vitro fertilization (IVF) in New South Wales (Australia); the National Health Service Scotland; and by Prof. Seher Basaran of Istanbul University (Turkey) a leader in the field of prenatal screening to identify potential chromosomal abnormalities, who confirmed, "CytoVision with GSL-120 is a vital addition to our facility Istanbul University (Turkey; www.istanbul.edu.tr) enabling us to provide results to clinicians sooner and cope with the increased need for cytogenetic screening."

Charles de Rohan, CEO Genetix, commented: "The CytoVision platform is now used in almost 2000 facilities. The rapid adoption of the GSL-120 system across all continents clearly demonstrates that we are fulfilling the needs of busy cytogenetics laboratories."

Related Links:
Genetix
Sydney Genetics
Istanbul University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.